In Vitro Diagnostics Test Kit Market Report 2025 (Global Edition)

Global In Vitro Diagnostics Test Kit Market Report 2025 Market Size Split by Type (Services Fully-automated Instruments, Semi-automated Instruments, Others), by End-Use (Laboratories, Hospitals, Acade...

In Vitro Diagnostics Test Kit Market Report Description

We have various report editions of In Vitro Diagnostics Test Kit Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the In Vitro Diagnostics Test Kit Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

In Vitro Diagnostics Test Kit Industry News

• March 2023: QIAGEN partnered with Servier to create a companion diagnostic test for TIBSOVO, which is distinguished for treating blood cancer and acute myeloid leukemia.

(Source: https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2023/QIAGEN-and-Servier-Partner-to-Develop-Companion-Diagnostic-for-Acute-Myeloid-Leukemia-AML-Therapy-Drug/default.aspx )

Top Companies Market Share in In Vitro Diagnostics Test Kit Industry: (In no particular order of Rank)

• Biomerieux SA
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Becton
• Dickinson
• and Company
• Bio-Rad Laboratories Inc.
• Abbott Laboratories
• Arkray Inc.
• Sysmex Corporation
• Siemens Healthcare GmbH
• Thermo Fischer Scientific Inc.
• Qiagen NV
• Grifols SA
• AgilentTechnologies Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region dominates the Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. This innovative kit integrates cutting-edge technology to deliver accurate results, meeting the demands of modern healthcare settings. With its user-friendly interface and robust design, healthcare professionals can rely on this comprehensive solution to streamline diagnostic processes, enhancing patient care and clinical outcomes across the continent.

Which Region is Expanding at the Fastest CAGR?

Europe is the fastest-growing region over the projected period, owing to the growing prevalence of numerous chronic diseases, rapidly rising population, increasing investment in the R&D by governments and private firms, supportive government regulation, and rising preference for in vitro diagnostics test kits by doctors and clinicians for accurate diagnosis of numerous diseases, the market is projected to develop over the forecast period.

The current report Scope analyzes In Vitro Diagnostics Test Kit Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America In Vitro Diagnostics Test Kit Market Analysis

According to Cognitive Market Research, the global in vitro diagnostics test kit market size was estimated at USD 103512.2 Million, out of which North America held the major market of more than 40% of the global revenue with market size of USD 41404.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031 due to technological advancements in diagnostic tools, increasing demand for personalized medicine, and robust healthcare infrastructure, fostering widespread adoption and market growth in the region. According to Cognitive Market Research, point-of-care testing offers rapid, convenient, decentralized diagnostic solutions, facilitating immediate clinical decision-making. With increasing emphasis on personalized medicine and healthcare decentralization, point-of-care testing adoption is accelerating, propelling market growth in the region. In conclusion, the in vitro diagnostics test kit market in North America is driven by a rise in the incidence of infectious diseases.

• According to Cognitive Market Research, the US had a major share in the in vitro diagnostics test kit market, with a market size of USD 32668.45 million in 2024, and is projected to grow at a CAGR of 3.5% during the forecast period. The nation’s increasing availability of a wide range of in vitro diagnostics test kits.
• The Canadian in vitro diagnostics test kit market had a market share of USD 4968.59 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. The nation's increasing demand for rapid and self-test kits.
• The Mexico in vitro diagnostics test kit market is projected to grow at a CAGR of 4.2% during the forecast period, with a market size of USD 3767.84 million in 2024.

Europe In Vitro Diagnostics Test Kit Market Analysis

According to Cognitive Market Research, the global in vitro diagnostics test kit market size was estimated at USD 103512.2 Million, out of which Europe held the major market of more than 30% of the global revenue with market size of USD 31053.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031 due to the presence of stabilizing economies, rapidly rising middle-class population, supporting government policies, and immediate urbanization across the region. According to Cognitive Market Research, software solutions streamline test result interpretation, enhance data accuracy, and improve efficiency in healthcare settings. As regulations tighten and the need for integrated healthcare systems grows, adopting such software becomes pivotal in optimizing diagnostic processes. In conclusion, developing automated in vitro diagnostics test kits for laboratories and hospitals drives the region's in vitro diagnostics test kit market.

• The United Kingdom's in vitro diagnostics test kit market had a market share of USD 5217.01 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. This is due to the country's continuous innovations in technological aspects.
• The French in vitro diagnostics test kit market is projected to grow at a CAGR of 3.2% during the forecast period, with a market size of USD 2856.94 million in 2024.
• According to Cognitive Market Research, the size of the German in vitro diagnostics test kit market was valued at USD 6148.62 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, the in vitro diagnostics test kit market surged due to the development of automated hospital systems. 
• The Italian in vitro diagnostics test kit market is projected to grow at a CAGR of 3.4% during the forecast period, with a market size of USD 2670.61 million in 2024.
• The Russian in vitro diagnostics test kit market is projected to grow at a CAGR of 3.0% during the forecast period, with a market size of USD 4813.32 million in 2024.
• The Spanish in vitro diagnostics test kit market is projected to grow at a CAGR of 3.1% during the forecast period, with a market size of USD 2546.40 million in 2024.
• The Luxembourg in vitro diagnostics test kit market is projected to grow at a CAGR of 4.1% during the forecast period, with a market size of USD 962.66 million in 2024.
• The Portugal in vitro diagnostics test kit market is projected to grow at a CAGR of 3.8% during the forecast period, with a market size of USD 652.13 million in 2024.
• The Greece in vitro diagnostics test kit market is projected to grow at a CAGR of 4.3% during the forecast period, with a market size of USD 372.64 million in 2024.
• The Rest of Europe's in vitro diagnostics test kit market is projected to grow at a CAGR of 2.7% during the forecast period, with a market size of USD 4813.32 million in 2024.

Asia Pacific In Vitro Diagnostics Test Kit Market Analysis

According to Cognitive Market Research, the global in vitro diagnostics test kit market size was estimated at USD 103512.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 23807.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031 due to region's growing population of patients impacted by chronic disorders and a rising number of research endeavors connected to in vitro diagnostics test kit drives growth of the market in the region. According to Cognitive Market Research, the increasing adoption of patient self-testing drives the market. This trend is fueled by the growing prevalence of chronic diseases, rising healthcare awareness among individuals, and the demand for convenient and cost-effective diagnostic solutions for home use. In conclusion, the region's in vitro diagnostics test kit market is driven by the rising number of in vitro diagnostics test kits being launched by key players.

• According to Cognitive Market Research, the size of the Chinese in vitro diagnostics test kit market size was valued at USD 10713.51 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. This is due to the presence of a large number of key players.
• The Japan in vitro diagnostics test kit market is projected to grow at a CAGR of 6.0% during the forecast period, with a market size of USD 3285.48 million in 2024. This is due to the country's advancement in healthcare infrastructure.
• The India in vitro diagnostics test kit market had a market share of USD 2856.94 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. 
• The South Korean in vitro diagnostics test kit market is projected to grow at a CAGR of 6.6% during the forecast period, with a market size of USD 2380.78 million in 2024.
• The Australian in vitro diagnostics test kit market is projected to grow at a CAGR of 7.2% during the forecast period, with a market size of USD 1238.01 million in 2024.
• The South East Asia in vitro diagnostics test kit market is projected to grow at a CAGR of 8.5% during the forecast period, with a market size of USD 1642.74 million in 2024.
• The Rest of Asia Pacific in vitro diagnostics test kit market is projected to grow at a CAGR of 7.3% during the forecast period, with a market size of USD 1690.35 million in 2024.

South America In Vitro Diagnostics Test Kit Market Analysis

According to Cognitive Market Research, the global in vitro diagnostics test kit market size was estimated at USD 103512.2 Million, out of which Latin America market has more than 5% of the global revenue with market size of USD 5175.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031 due to increasing government initiatives to improve healthcare infrastructure, and growing demand for point-of-care testing. These factors foster the adoption of diagnostic kits and enhance healthcare outcomes across the region. According to Cognitive Market Research, online retailers offer convenient access to a wide range of diagnostic kits, catering to the region's growing demand for affordable healthcare solutions in the region. In conclusion, the region's in vitro diagnostics test kit market is driven by technological advancements in accuracy, portability, and cost-effectiveness.

• According to Cognitive Market Research, Brazil's in vitro diagnostics test kit market size was valued at USD 2215.16 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. In vitro diagnostics test kit sales flourish in Brazil due to the nation's increasing use of point-of-care (POC) diagnostics.
• The Argentina in vitro diagnostics test kit market had a market share of USD 869.50 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. There is an increasing number of incurable life-threatening diseases across the nation.
• The Colombia in vitro diagnostics test kit market is projected to grow at a CAGR of 4.7% during the forecast period, with a market size of USD 460.63 million in 2024.
• The Peru in vitro diagnostics test kit market is projected to grow at a CAGR of 5.1% during the forecast period, with a market size of USD 424.40 million in 2024.
• The Chile in vitro diagnostics test kit market is projected to grow at a CAGR of 5.2% during the forecast period, with a market size of USD 372.64 million in 2024.
• The Rest of Latin America's in vitro diagnostics test kit market is projected to grow at a CAGR of 4.0% during the forecast period, with a market size of USD 833.27 million in 2024.

Middle East In Vitro Diagnostics Test Kit Market Analysis

According to Cognitive Market Research, the global in vitro diagnostics test kit market size was estimated at USD 103512.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with market size of USD 2070.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031 due to increasing investments in healthcare infrastructure, expanding access to diagnostic services, and a growing focus on combating infectious diseases like HIV/AIDS and malaria. These factors fuel the region's demand for rapid and accurate diagnostic solutions. According to Cognitive Market Research, independent stores serve as convenient access points for consumers, particularly in remote areas with limited healthcare infrastructure, facilitating the distribution and availability of diagnostic testing kits across the region. In conclusion, the region's in vitro diagnostics test kit market is driven by the increasing prevalence of diabetics.

• According to Cognitive Market Research, the GCC Countries' in vitro diagnostics test kit market size was valued at USD 886.06 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. In vitro diagnostics test kit sales flourish in the GCC Countries due to the region's increasing burden of chronic diseases worldwide.
• The Egyptian in vitro diagnostics test kit market is projected to grow at a CAGR of 5.5% during the forecast period, with a market size of USD 217.38 million in 2024.
• The South African in vitro diagnostics test kit market is projected to grow at a CAGR of 6.2% during the forecast period, with a market size of USD 327.10 million in 2024. Family entertainment center sales flourish in South Africa due to the region's stringent regulations regarding product approvals.
• The Turkish in vitro diagnostics test kit market is projected to grow at a CAGR of 4.3% during the forecast period, with a market size of USD 178.04 million in 2024.
• The Nigeria in vitro diagnostics test kit market is projected to grow at a CAGR of 4.3% during the forecast period, with a market size of USD 217.38 million in 2024.
• The Rest of MEA in vitro diagnostics test kit market is projected to grow at a CAGR of 4.2% during the forecast period with a market size of USD 244.29 million in 2024.

In Vitro Diagnostics Test Kit Market Analysis

In Vitro Diagnostics Test Kit Type Segment Analysis

According to Cognitive Market Research, services fully-automated instruments hold a prominent market share due to rising demand for early disease detection and monitoring. Fully automated instruments streamline testing processes, enhancing efficiency and accuracy, while increasing the adoption of point-of-care diagnostics amplifies market growth.

Semi-automated instruments are the fastest-growing category over the forecast period due to the rising prevalence of infectious diseases, technological advancements, and demand for rapid and accurate diagnostic solutions. Semi-automated instruments streamline testing processes, enhancing efficiency and accuracy in diagnostic laboratories.

• Services Fully-automated Instruments
• Semi-automated Instruments
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of In Vitro Diagnostics Test Kit Industry. Request a Free Sample PDF!

In Vitro Diagnostics Test Kit Application Segment Analysis

According to Cognitive Market Research, hospitals hold a prominent market share due to a rise in the rate of hospitalizations requiring support from faster diagnostics. Furthermore, the ongoing expansion of healthcare infrastructure and favorable initiatives taken by government bodies are expected to improve the current hospital facilities. 

Point-of-care testing is the fastest-growing category over the forecast period due to patients' rising preference for physician's offices for point-of-care tests. Additionally, the increased adoption of rapid point-of-care tests for diagnosing chronic and infectious diseases, such as diabetes and hepatitis, in physicians' offices is anticipated to drive the segment's growth.

• Laboratories
• Hospitals
• Academics
• Point-Of-Care Testing
• Patient Self-Testing
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

In Vitro Diagnostics Test Kit Product Type Segment Analysis

According to Cognitive Market Research, reagents & kits held the major market stake over the projected period due to the rising number of reagent kits available in the industry to self-diagnose disease and infection at home. Such IVD kits consist of materials that can be utilized to choose the outcome of a given test. 

Instruments are the fastest-growing category over the forecast period owing to advancements in automation and technology, increased adoption of in vitro diagnostic testing, and the need for faster and more efficient diagnostic processes in clinical laboratories and healthcare settings. 

• Instruments
• Reagents & kits.
• Data Management Software

In Vitro Diagnostics Test Kit Price Segment Analysis

According to Cognitive Market Research, $ 100- $ 250 holds a major market share due to increasing demand for rapid and accurate diagnostic solutions, technological advancements in healthcare, increasing prevalence of chronic diseases, and growing awareness about early disease detection. Prices typically range from $100 to $250, catering to various healthcare budgets.

The $30 to $ 100 is the fastest-growing category over the forecast period due to the increasing prevalence of chronic diseases and rising demand for point-of-care testing. With prices ranging from $30 to $100, accessibility and affordability further contribute to market growth, particularly in low-resource settings.

• Below US$ 30
• US$ 30 - US$ 100
• US$ 100- US$ 250
• US$ 250 — US$ 1000
• Above US$ 1000

In Vitro Diagnostics Test Kit Sales Channel Segment Analysis

According to Cognitive Market Research, hypermarkets/supermarkets hold a prominent market share due to technological advancements and the increasing prevalence of chronic diseases. Hypermarkets/supermarkets contribute by offering convenience and accessibility for consumers to purchase these kits alongside regular shopping, further boosting market penetration.

Online retailers are the fastest-growing category over the forecast period due to the rising prevalence of infectious diseases. Online retailers play a crucial role in distribution, providing accessibility and convenience to consumers seeking these essential healthcare products.

• Hypermarkets/Supermarkets
• Independent Stores
• Specialty Stores
• Online Retailers
• Direct Sales
• Other Sales Channel

Author's Detail

Swasti Dharmadhikari

Research associate at Cognitive Market Research

LinkedIn

Profile

Swasti Dharmadhikari, an agile and achievement-focused market researcher with an innate ardor for deciphering the intricacies of the Service & Software sector. Backed by a profound insight into technology trends and consumer dynamics, she has committed herself to meticulously navigating the ever-evolving terrain of digital Services and software solutions.

Author's Conclusion